Olin Corporation

The latest read

Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.

• Revenue over the four quarters to June 30, 2026: $6.70 billion, up 0.6% from a year earlier.SEC EDGAR filings (XBRL)
• Free cash flow (operating cash flow minus capital expenditure) over the four quarters to March 31, 2025: $0.12 billion, down 85% from a year earlier.SEC EDGAR filings (XBRL)
• Capital expenditure over the four quarters to March 31, 2025: $0.21 billion, down 4.5% from a year earlier.SEC EDGAR filings (XBRL)
• Share buybacks in the fiscal year to December 31, 2025: $0.05 billion.SEC EDGAR filings (10-K)
• Long-term debt issued in the fiscal year to December 31, 2025: $2.76 billion.SEC EDGAR filings (10-K)
• Latest earnings call or results release (July 31, 2026): sentiment -0.20 on a −1 to +1 scale (negative), confidence 0.40 of 1.Palanor Discourse
• Latest annual report (filed February 20, 2026): 0 risk factors added, 2 removed.Risk Factor Changes (10-K Item 1A)
• Insiders were net sellers in Q1 2026: $2.4 million on the open market.SEC Form 4
• 412 institutional managers reported a position at June 30, 2026 (−10 on the quarter before).SEC Form 13F

Risk events (12 months): 1 — latest EPA enforcement case, Dec 3, 2025 →

Company Posture covers S&P 500 companies.

No bond term sheets or tagged debt on file for Olin Corporation yet.

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

1. Oct 20, 2026Lobbying
   Lobbying report (MONUMENT ADVOCACY)third_quarter 2026 · $0.1 million
2. Oct 19, 2026Lobbying
   Lobbying report (OLIN CORPORATION)third_quarter 2026 · $0.2 million
3. Oct 16, 2026Lobbying
   Lobbying report (S-3 GROUP)third_quarter 2026 · $0.1 million
4. Oct 16, 2026Lobbying
   Lobbying report (COVENANT GOVERNMENT AFFAIRS, LLC)third_quarter 2026 · $0.1 million
5. Oct 8, 2026Lobbying
   Lobbying report (LIZ WILLIAMS AND COMPANY)third_quarter 2026 · $0.0 million
6. Sep 15, 2026Patent
   Patent granted: METHOD FOR TREATING A HEAVY BYPRODUCT STREAM FROM CHLORINATED PROPANE PRODUCTIONUS 12735373
7. Aug 25, 20268-K
   Shareholder vote resultsItem 5.07
8. Jul 20, 2026Lobbying
   Lobbying report (MONUMENT ADVOCACY)second_quarter 2026 · $0.1 million
9. Jul 20, 2026Lobbying
   Lobbying report (OLIN CORPORATION)second_quarter 2026 · $0.3 million
10. Jul 9, 2026Lobbying
    Lobbying report (COVENANT GOVERNMENT AFFAIRS, LLC)second_quarter 2026 · $0.1 million
11. Jul 7, 2026Trademark
    Trademark application: AUTOBUCK
12. Jul 7, 2026Trademark
    Trademark application: BC MAX
13. Jul 7, 2026Trademark
    Trademark application: AMERICAN LEVER RANGE
14. Jun 23, 2026Trademark
    Trademark application: OLINHUNTSMAN
15. Jun 16, 20268-K
    Material agreement signedItem 1.01
16. May 21, 20268-K
    Shareholder vote resultsItem 5.07
17. May 15, 2026Trademark
    Trademark application: DOUBLE A
18. Apr 30, 20268-K
    Director or officer changeItem 5.02
19. Apr 30, 20268-K
    Shareholder vote resultsItem 5.07
20. Feb 20, 202610-K
    Annual report (10-K)0 risk factors added, 2 removed
21. Dec 3, 2025Risk event
    EPA judicial case: OLIN OU2 SUPERFUND SITE (RD/RA AND COST RECOVERY)EPA_ECHO
22. Aug 19, 2025Patent
    Patent granted: NOVEL HARDENER FORMULATION FOR COLD CURING EPOXY SYSTEMSUS 12391792
23. Jun 12, 2025Risk event
    EPA judicial case: Sangamo Electric Dump/Crab Orchard National Wildlife Refuge (USDOI) (AUS OU) Cost RecoveryEPA_ECHO
24. May 1, 20258-K
    Shareholder vote resultsItem 5.07
25. Mar 14, 20258-K
    Material agreement signedItem 1.01
26. Mar 14, 20258-K
    Material agreement terminatedItem 1.02
27. Mar 6, 20258-K
    Director or officer changeItem 5.02
28. Feb 20, 202510-K
    Annual report (10-K)0 risk factors added, 0 removed
29. Jan 21, 20258-K
    Director or officer changeItem 5.02
30. Dec 10, 20248-K
    Director or officer changeItem 5.02
31. Nov 21, 20248-K
    Director or officer changeItem 5.02
32. Nov 20, 20248-K
    Material agreement signedItem 1.01
33. Nov 20, 20248-K
    Material agreement terminatedItem 1.02
34. Feb 22, 202410-K
    Annual report (10-K)2 risk factors added, 2 removed
35. Jan 23, 2024Patent
    Patent granted: STADIUM SEATUS 11877660
36. Jan 9, 2024Patent
    Patent granted: COMPOUND SHELL CASING, AND AMMUNITION HAVING COMPOUND SHELL CASINGUS 11867492
37. Oct 31, 2023Patent
    Patent granted: BRINE PURIFICATION PROCESSUS 11802060

Peers

Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

Identity

SEC CIK

74303

LEI

549300GKK294V7W57P06

Wikidata

Q7086908